![](/img/cover-not-exists.png)
A Phase 1B Clinical Study of Combretastatin A1 Diphosphate (OXi4503) and Cytarabine (ARA-C) in Combination (OXA) for Patients with Relapsed or Refractory Acute Myeloid Leukemia
Uckun, Fatih M., Cogle, Christopher R., Lin, Tara L., Qazi, Sanjive, Trieu, Vuong N., Schiller, Gary, Watts, Justin M.Volume:
12
Journal:
Cancers
DOI:
10.3390/cancers12010074
Date:
December, 2019
File:
PDF, 958 KB
2019